Aeglea Biotherapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $659k | 39k | 16.76 |
| 2025-06-30 | $515k | 34k | 14.97 |
| 2025-03-31 | $485k | 30k | 16.14 |
| 2024-12-31 | $575k | 25k | 23.28 |
| 2024-09-30 | $524k | 18k | 29.41 |
| 2024-06-30 | $404k | 17k | 23.51 |
| 2024-03-31 | $85k | 2.2k | 37.93 |
| 2023-12-31 | $494 | 23 | 21.52 |
| 2023-09-30 | $269 | 22 | 12.27 |